.Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01F_MacrolidesLincosamidesAndStreptogramins.J01FA06_Roxithromycin.Roxithromycin

Information

name:Roxithromycin
ATC code:J01FA06
route:oral
n-compartments2

Roxithromycin is a semi-synthetic macrolide antibiotic derived from erythromycin. It is used for the treatment of respiratory tract, urinary, and soft tissue infections caused by susceptible organisms. It is approved for use in multiple countries, but its use may be limited or not approved in the United States.

Pharmacokinetics

Pharmacokinetic parameters reported for healthy adult volunteers following a single oral dose of roxithromycin.

References

  1. Bizjak, ED, & Mauro, VF (1997). Digoxin-macrolide drug interaction. The Annals of pharmacotherapy 31(9) 1077–1079. DOI:10.1177/106002809703100918 PUBMED:https://pubmed.ncbi.nlm.nih.gov/9296249

Revisions


Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos